Grifols | GRFS - Ativos





Ativos Alterar Data
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
Arca Biopharma USD 1.14B 634.91M 2026-06
aTyr Pharma USD 69.82M 9.83M 2026-06
Bio Path USD 677K 13K 2026-03
Brainstorm Cell Therapeutics USD 788K 33K 2026-06
Capricor Therapeutics USD 368.74M 42.45M 2026-06
Cara Therapeutics USD 25.82M 6.26M 2026-03
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
Grifols EUR 23.15B 142.7M 2025-12
Immunic USD 189.74M 165.69M 2026-03
Minerva Neurosciences USD 97.97M 69.88M 2025-12
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Sangamo BioSciences USD 97.56M 11.39M 2025-06
TherapeuticsMD USD 40.13M 1.96M 2024-06